Bruce Rosen, MD, PhD. Dr. Rosen is Professor of Radiology at the Harvard Medical School and Professor of Health Science and Technology at the Harvard-MIT Division of Health Sciences and Technology. He is Director of the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital. Dr. Rosen is a world-leading expert in functional neuroimaging. Over the past thirty years he has pioneered the development and application of many novel physiological and functional nuclear magnetic resonance techniques to measure hemodynamic and metabolic changes associated with brain activation and cerebrovascular insult as well as complementary tools to measure microvascular and microstructural morphology. These and other techniques he has developed are used by research centers and hospitals throughout the world to study and evaluate patients with stroke, brain tumors, dementia, and neurologic and psychological disorders. Most recently, Dr. Rosen’s work has focused on the integration of fMRI data with information from other modalities, including positron emission tomography (PET), magnetoencephalography (MEG) and noninvasive optical imaging. By using fMRI tools to evaluate the linkage between neuronal and physiological (metabolic and hemodynamic) events during periods of increased neuronal activity, his studies will allow researchers to better interpret fMRI signal changes and develop new ways to probe brain function. Dr. Rosen leads the activities of several large interdisciplinary and inter-institutional research programs including the NIH Blueprint-funded Human Connectome Project, the NIBIB Regional Resource Center, the Center for Functional Neuroimaging Technologies (CFNT), and the Biomedical Informatics Research Network (BIRN) Collaborative Tools Support Network. He is Principal Investigator/Program Director for two neuroimaging training programs. He has authored more than 300 peer-reviewed articles as well as over 50 book chapters, editorials and reviews. Dr. Rosen is the recipient of numerous awards in recognition of his contributions to the field of functional MRI, including, most recently, the 2011 Outstanding Researcher award from the Radiological Society of North America (RSNA), and the Rigshospitalets International KFJ Prize from the University of Copenhagen/Rigshospitalet. Dr. Rosen is a Fellow and Gold Medal winner for his contributions to the field of Functional MRI from the International Society for Magnetic Resonance in Medicine, a Fellow of the American Institute for Medical and Biological Engineering, and a member of the Institute of Medicine of the National Academies. 

Title of speech: advances in autism brain imaging studies

罗森博士是美国医学和生物工程院士，美国医学科学院院士，麻省总医院Athinoula A.Martinos生物医学影像中心主任，哈佛医学院放射科教授、哈佛 大学- 麻省理工学院健康科学和技术部卫生科学与技术教授。罗森博士是功能性神经影像学领域的世界领先专家。在过去的三十多年，他开创了很多新的生理和功能性核磁共振技术，应用于测量大脑活动和脑损伤相关的血流动力学和代谢变化，也为有关微血管和微观结构形态的代谢变化测定提供了辅助工具。他开发这些和其它技术在世界各地的研究中心和医院运用，以研究和评估患者的中风、脑肿瘤、老年痴呆症和神经和心理障碍性疾病。最近，罗森博士的工作主要集中在整合功能磁共振成像和其他检查来源的信息和资料，包括正电子发射断层扫描（PET）、脑磁图（MEG）和无创光学成像。通过使用fMRI这一工具来评估神经元活动增加期间的神经和生理（代谢和血液动力学）事件之间的联系，他的研究使得研究人员能更好地解释功能磁共振成像（fMRI)的信号变化，并开发新的方法来探测脑功能。

罗森博士领导几项大型跨学科和跨机构的研究计划，包括NIH蓝图计划（NIH-Blueprint）资助的人类连接组项目（Human Connectome Project)，NIBIB区域性资源中心，功能神经影像技术中心（CFNT），以及生物医学信息学研究网络（BIRN ）协作工具支持网络（Biomedical Informatics Research Network (BIRN) Collaborative Tools Support Network）。他是神经影像学培训课程首席研究员两个项目的主管。他撰写了300多同行评议的文章，以及超过50本书的章节、社论和评论。

罗森博士获得了众多奖项，以表彰他为功能性磁共振成像领域的贡献，其中包括北美放射学会（RSNA）2011年杰出研究奖以及哥本哈根/ Rigshospitalet大学的Rigshospitalets国际KFJ奖。

罗森博士为国际核磁共振协会会员和磁共振功能磁共振成像领域的贡献的金奖获得者，美国医学和生物工程院士，美国医学科学院院士。

他的主题讲演题目：自闭症大脑影像学的新进展

Matthew Anderson, MD, PhD. Associate Professor of Harvard Medical school, and Principal Investigator in the Departments of Pathology and Neurology and Director of Neuropathology at Beth Israel Deaconess Medical Center. The Anderson Laboratory studies the molecular, cellular and neural network mechanisms responsible for disorders of membrane excitability and synaptic transmission in the central nervous system. See more at the site: http://www.bidmc.org/Research/Departments/Neurology/Laboratories/Matthew...Increases of Ube3a gene dosage cause autism (maternal isodicentric chromosome 15 [idic15], maternal Ube3a triplication; Smith et al. Sci Transl Med), while maternal Ube3a loss causes Angelman syndrome. In mature neurons, Ube3a is expressed exclusively from the maternal allele; the paternal Ube3a allele is repressed. Ube3a acts as an E3 ubiquitin ligase but also separately as a transcriptional co-activator. To determine whether excess Ube3a causes autism behavioral deficits via actions in the neuronal cytoplasm/synapse or nucleus, he engineered a nuclear importing peptide signal to the C-terminus of Ube3a. We have further engineered the Ube3a transgene to permit neuron subtype and brain region specific increases of Ube3a gene dosage to enable circuit mapping of the autism-associated behavioral defects. A detailed analysis of circuit-specific changes in gene expression (ribotag) and physiology (optogenetic manipulations and neural circuit studies) will follow. He is also now investigating the neural circuit basis of increased aggression in this autism disorder. He is also investigating the function other autism genes with direct protein-protein interacts with the Ube3a-regulated genes to identify common autism pathways. In separate projects we are investigating the functional consequences of the genomic changes that occurred during hominid evolution and might underlie human cognitive abilities. Such changes are accompanied by altered gene expression in the cerebral cortex, so he is focused on a hominid-specific non-coding RNA altered as a CNV in autism. Genome editing and transcript profiling in cell lines explores the molecular mechanisms of the hominid-specific change in gene regulation. He introduce the hominid-specific changes into the mouse genome to reconstitute the molecular step in hominid evolution in a living lower mammal to permit detailed studies of behavior, circuit physiology, and gene expression.

Speech title: Nucleating an Autism Gene Network

安德森博士是神经病理顶级专家，哈佛医学院教授，哈佛医学院附属贝斯以色列医院神经病理系主任, 实验室主任及课题带头人。他的实验室主要研究神经系统疾患的分子及细胞学机理。他在自闭症发病机理方面，动物模型，特定基因表达与自闭症亚型都有极为深入的研究，处在国际领先地位，在“科学”自然” “细胞“等顶级杂志均不断有专著文章发表。

他的讲演题目:自闭症基因系统的核心发现

Martha Herbert, M.D., Ph.D., Dr. Herbert is Assistant professor of neurology at Harvard Medical School and a pediatric neurologist at Massachusetts General Hospital, where she is the director of the TRANSCEND Research Program. She is the co-founder and co-director of body brain resilience center. She is an affiliate of the Harvard-MGH-MIT-HST Martinos Center for Biomedical Imaging. Dr. Herbert earned her medical degree at the Columbia University College of Physicians and Surgeons. Prior to her medical training she obtained a doctoral degree at the University of California, Santa Cruz, studying evolution and development of learning processes in biology and culture in the History of Consciousness program, and then did postdoctoral work in the philosophy and history of science. She trained in pediatrics at Cornell University Medical Center and in neurology and child neurology at Massachusetts General Hospital, where she has remained. She received the first Cure Autism Now Innovator Award and is on the Scientific Advisory Committee of Autism Speaks.

Title of speech: Autism revolution, a whole body approach

玛莎·赫伯特，医学博士，哲学博士

Martha Herbert, M.D., Ph.D.,

玛莎赫伯特博士是美国著名自闭症专家，哈佛麻州总医院TRANSCEND神经研究所主任，哈佛医学院小儿神经学教授，机体大脑康复中心共同主任。赫伯特博士从事自闭症研究20年之久，是同行们公认的顶级自闭症专家，她在大脑电生理尤其定量脑电图，脑磁图，大脑代谢性影像方面造诣精深，率先提出自闭症为全身性疾患及大脑神经可塑性的概念，成为美国著名电视媒体的嘉宾经常接受采访，并应邀在世界各地讲学，她得到治愈自闭症第一个创新奖（Cure Autism Now Innovator Award），是自闭症之声（Autism Speaks Committee）的科学顾问委员会顾问，著有“自闭症革命”畅销书，近期由人民卫生出版社出版中译本。

演讲题目：自闭症的革命，全身疗法

Other featured speakers:

William Stone, Ph.D., ABPP-CN, Dr. Stone is Director of Neuropsychology Training and Clinical Services, Massachusetts Mental Health Center (MMHC); Director of Neuropsychology Fellowship Program at MMHC and Beth Israel Deaconess Medical Center (BIDMC); Assistant Professor of Psychology, Harvard Medical School, staff clinical psychologist of department of psychiatry, BIDMC. His research is focused on identifying cognitive, clinical and biological risk factors for the development of psychiatric illness. These efforts emphasize attempts to identify liability syndromes for schizophrenia and related disorders. They also aim to develop interventions that will alter or prevent the trajectory to psychosis and other manifestations of major mental illness.

Title of speech: Early diagnosis of autism and guideline in USA

威廉·斯通，哲学博士，ABPP-CN

斯通博士是麻州精神卫生中心（MMHC）神经心理学培训和临床主任; MMHC神经心理学奖学金项目主任。他是哈佛医学院心理学副教授，哈佛医学院附属BIDMC精神病学临床心理学课题主任，他的研究主要集中在识别精神疾病的发生发展中来自认知、临床和生物学相关的危险因素。早年他主攻精神分裂症和相关病症的综合征。近年致力于自闭症的诊断评估及研究，发现自闭症与精神分裂症有很多共性，开发能改变或阻止精神病和其他表现形式的重性精神疾病的的干预措施。

演讲题目：孤独症的早期诊断

Richard Frye, MD, PhD. Dr. Frye is the Director of Autism Research at Arkansas Children’s Hospital Research Institute and Director of the Autism Multispecialty Clinic at Arkansas Children’s Hospital in Little Rock, AR. Dr. Frye is a well-recognized expert in the diagnosis and treatment of Autism Spectrum Disorders (ASD) and other developmental disorders. Dr. Frye has a broad background including specific training in neurodevelopmental disorders, physiology, psychology, and biostatistics. He is fellowship trained in Behavioral Neurology and Psychology and has clinical expertise in the assessment, diagnosis, and treatment of children with ASD. While at the University of Texas he developed a medically-based autism clinic which was specifically designed to diagnose and treat neurological and metabolic abnormalities associated with ASD in order to improve quality of life and promote recovery. Over the past two years he has completed three clinical studies related to ASD, including an open-label trial examining the metabolic and behavioral effects of tetrahydrobiopterin, a clinical study of the metabolic and genetic characteristics of children with ASD and mitochondrial disease, and a clinical study on the prevalence of the folate receptor alpha autoantibody in children with ASD, as well as the response to leucovorin treatment in ASD children with the folate receptor alpha autoantibody. As Director of Autism Research at the Arkansas Children’s Hospital his goal is to develop an integrated autism program that includes a multi-specialty autism clinic, a translational research program focusing on biomarkers and clinical-trials, and a basic science program focusing on mitochondrial and redox metabolic metabolism.

Titles of speech: 1-2 of the following

Neurometabolic Disorders Associated with Autism

Mitochondrial Disorders in Autism

Cerebral Folate Deficiency in Autism

Treatable Disorders Associated with Autism

理查德·弗莱，医学博士，哲学博士

Richard Frye, MD, PhD. 

弗莱博士是阿肯色儿童医院研究所自闭症研究室主任，小石城阿肯色儿童医院自闭症多专业诊所主任。

弗莱博士是自闭症谱系障碍（ASD）和其他发育障碍的诊断和治疗公认的领先专家。

弗莱博士有着广泛的背景，包括在神经发育障碍、生理学、心理学和生物统计学的专门培训。

他接受过行为神经学和心理学专科训练，是评估、诊断和治疗小儿ASD方面临床专家。

而在得克萨斯大学时，他开发了一个医学为基础的自闭症诊所，这是专门设计用于诊断和治疗与ASD相关的神经系统和代谢异常，以提高生活质量，促进康复。

在过去的两年中，他已经完成了相关的ASD三项临床研究，包括开放标签试验研究代谢和四氢生物蝶呤行为的影响，儿童自闭症和线粒体疾病的代谢和遗传特征的临床研究和临床研究儿童孤独症的叶酸受体α自身抗体的患病率，以及在叶酸受体α自身抗体阳性的ASD患儿采用亚叶酸钙（leucovorin）治疗的反应。

作为在阿肯色儿童医院自闭症研究主任，他的目标是建立一个综合的自闭症方案，其中包括一家多专业自闭症诊疗，专注于生物标志物和临床试验平移研究计划，以及基础科​​学计划侧重于线粒体和氧化还原的代谢。

演讲标题：

自闭症有关的神经代谢障碍

自闭症的线粒体疾病

自闭症脑叶酸缺乏

与孤独症相关的可治疗疾病

Valerie W. Hu, Ph.D., is a Professor of Biochemistry and Molecular Medicine at The George Washington University School of Medicine and Health Sciences in Washington, DC as well as the mother of a son with an autism spectrum disorder (ASD). Dr. Hu was trained as a chemist, with a Ph.D. in Chemistry from the California Institute of Technology and a B.S. in Chemistry from the University of Hawaii. She has a long research history in cross-disciplinary studies focused on protein structure-function relationships and membrane-protein interactions. In late 2004, because of her personal interest in ASD, she redirected her research focus towards autism, with long-range goals of developing biomarker-based diagnosis and personalized treatment of autism spectrum disorders. Dr. Hu has since become a leader in the application of multi-disciplinary, integrative genomics approaches to ASD which involve the integration of large-scale data from gene expression, behavioral, genetic, and epigenetic analyses, which are described in 18 research articles and reviews published since 2006. She is also the sole editor and one of the chapter authors for a recently released book entitled: Frontiers of Autism Research: New Horizons for Diagnosis and Treatment” (World Scientific, May 2014).

Title of speech: “An integrated genomics approach towards understanding: What causes autism?”

瓦莱丽·W·胡，哲学博士

瓦莱丽·W·胡博士是在华盛顿特区乔治·华盛顿大学医学院和健康科学生物化学与分子医学教授，在以及一个患有自闭症谱系障碍（ASD）儿子的母亲。

胡博士是一位化学家，拥有加州技术研究所（CIT）化学博士学位以及夏威夷大学化学学士学位（BS）。

她长期从事跨学科研究，主要集中在蛋白质结构与功能的关系和膜蛋白的相互作用。

因为她对ASD个人兴趣，在2004年年底她重新定向她的研究重点，转向自闭症研究，以发展生物标志物为基础的诊断和个性化治疗自闭症谱系障碍作为长期研究目标。

胡博士已经成长为多学科研究和基因组学综合应用的领军人物，对ASD基因表达、行为、遗传融合和表观遗传分析整合了大规模的分析数据，在这一方面，自2006年以来她发表了18篇研究论文和综述。最近在自闭症研究的前沿：新视野的诊断和治疗（世界科学，2014年5月）一书中发表了一个章节，她是该书的主编和唯一的编辑。

演讲题目：“一个集成的基因组学研究的方法针对：是什么原因导致自闭症？”

June (Xuejun) Kong, M.D. Dr. Kong is the founder and president of American Chinese Medical Exchange Society (ACMES), Faculty Physician and Researcher of Beth Israel Deaconess Medical Center, Harvard Medical School. As a mom of autistic son, to understand and cure autism became her lifetime passion and mission. Since 2000, she founded “Biomedical Solution of Autism”, “Institute to Cure Autism”, and co-founded “Body & Brain Resilience Center, autism family clinic”. She got extensively trained in autism related areas, she treated many autism individuals with not only biomedical but also integrative East meets West approaches, and conducted clinical or pre-clinical trials of many scientifically based treatments; She is a principal investigator for autism researches. Dr. Kong is not only a clinician, researcher, but also an executive leader and strong advocator, she organized many medical conference including international autism forums, Dr. Kong has brought together expert physicians, neuroscientists, neuroimaging specialists, psychologist, therapists, social workers to form clinical and research collaboration platform nationally and internationally, promote autism awareness and productive life. She is also founder and Editor-in-Chief of “North American Journal of Medicine & Science” and “North American Journal of Medicine & Health”, publishes autism special issues annually for the last 5 years with increasing impact.

Title of speech:

biomedical /integrative treatment of autism

孔学君医师，美中医学交流学会主席，哈佛医学院附属以色列医院临床医师及研究员，治愈自闭症研究所所长, 机体-大脑康复中心共同主任。孔医师毕业于北京医科大学医学系本科及研究生院，先后在北医第一附院及麻州大学医学院附属医院完成内科住院医师训练，并在塔芙兹医学院新英侖医学中心完成博士后研究， 1997年后一直在哈佛医学院附属医院从事临床，教学及科研工作。2000年后儿子诊断自闭症后专注于自闭症研究并建立了自闭症专业门诊，采用生物医学及整合医学新疗法为自闭症患者治疗，2010年创立“治愈自闭症研究所”并担任所长，多年来组织自闭症国际论坛，发表自闭症学术专刊共五期，并与著名自闭症专家玛莎赫伯特共同创立机体-大脑康复中心及自闭症诊所担任共同主任，致力于循证医学，系统生物学，功能医学，中西医结合为基础的自闭症诊疗，科研及康复。 2008年创立了“北美医学与健康”与“北美医学与科学”杂志并任主编。多年来致力于华人社团健康事业，主持大量涉及中美交流，学术会议的组织工作，现任美中医学交流学会主席。

讲演题目：自闭症生物医学治疗进展

Cun-Jian Dong, PhD. Dr. Dong was trained at top Chinese and US institutions and universities for his Master's and Ph.D. degrees and postdoctoral studies. He has been conducting translational research for nearly 20 years on understanding of neural injury mechanisms, disease pathogenesis, and development of new medicines for the treatment of CNS disease. He was a Research Investigator (a full professor level position) at Allergan Inc, a world top 500 multinational corporation. He is recognized internationally by his peers as an expert in neuroscience, particularly in the field of retinal neurobiology. He has also served as a guest reviewer of research grants for the US National Science Foundation, as well as for many international neuroscience and physiology journals. He is a member of the Society for Neuroscience, the Association for Research in Vision & Ophthalmology, and International Society for Clinical Electrophysiology of Vision.

His expertise and experience include: 1) pathogenesis of CNS disease, particularly retinal disease, and identification, characterization, and validation in animal models of novel drug targets; 2) development of in vivo, in vitro models, and assays for efficacy and safety tests; 3) design of high-throughput compound screens, selection of hit compounds, optimization of lead compounds and drug candidates, determination of their pharmacokinetics and toxicity, and optimization of drug formulations; 4) neuropharmacology and neurophysiology; 5) recruitment, training, and management of a drug development team; 6) management and coordination of drug development projects; 7) formulation and implementation of intermediate and long strategic plans for the project team. Dr. Dong is the research investigator and consultant of To Cure Autism Institute.

董存建博士在中美一流的院校和实验室及中美顶尖的神经科学学者的指导下完成硕士，博士学业和博士后训练（详细见其履历），长期从事神经系统疾病机理的研究和新药研发,是世界500强跨国药厂(Allergan Inc) 相当于正教授级别的研究员（Research Investigator)；在神经科学和视觉领域里是被国际同行所认定的专家，也是美国全国科学基金会(US National Science Foundation)科研基金的客座评审,多份国际神经科学和眼科杂志的客座评审；是美国神经科学学会(Society for Neuroscience), 美国眼科和视觉研究学会(The Association for Research in Vision & Ophthalmology， ARVO), 国际临床视觉电生理学会 (International Society for Clinical Electrophysiology of Vision)的会员。专长1）中枢神经系统疾病和眼科疾病的发病机理，新的药靶的寻找，确认和动物模型上的验证。2）离体，在体疾病模型，新的功能检测方法的建立及新的药物高通筛选的设计和实施，苗头，先导和候选药物化合物的优化，药代动力学特性和毒理的测定，最佳配方的选择。3）神经药理，中枢神经系统不同疾病的神经损伤机理。 4）科研和新药开发团队的组建，人员培训，管理和指导。5）管理和协调单位内外研发合作项目。6) 课题组/部门中，长期战略规划的制定与实施。现任美国平衡医药公司创始人及首席科学家治愈自闭症研究所研究员及顾问，课题主任。赴深圳首席科学家，负责基础科研实验室设置及技术顾问，并实施动物实验及其他科研。

讲演题目：自闭症的神经生理学进展

Dr. Albert Yeung is Director of Primary Care Research at the Depression Clinical and Research Program at Massachusetts General Hospital (MGH) and Associate Professor of Psychiatry at Harvard Medical School. He is the principal investigator of the study on “Evaluating changes in resting state networks before and after a Tai Chi training Intervention for Chinese Americans with depression”.

Dr. Yeung obtained his medical degree from National Taiwan University. He also obtained a Doctor of Science degree with a major in epidemiology from Harvard School of Public Health.  He completed residency training in psychiatry at MGH. 

Dr. Yeung's major research interests include integrating primary care and mental health services to improve treatment of depression, mental health issues of under-served populations, and the use of complementary and alternative methods in treating mood and anxiety disorders.  He has authored or co-authored over 80 original articles, numerous book chapters, and a book on self-management of depression.

Title of speech: "The use of tai chi for treatment of autism"

阿尔伯特·杨，医学博士，哲学博士

Albert Yeung，MD，PhD

Albert Yeung博士是在美国马萨诸塞州总医院（MGH）抑郁症临床研究计划初级保健研究主管、哈佛医学院精神病​学副教授。杨博士获得国立台湾大学医学学位，并在哈佛大学公共卫生学院获得科学学士学位和博士学位，主修流行病学，他还在MGH完成了精神病学住院医师培训。

他是“美裔华人太极训练之前和之后静息状态网络的变化在抑郁症治疗中的评估”这项研究的主要研究者。

杨博士主要研究方向是整合初级保健和心理健康服务，以改善抑郁症治疗，改善服务获得不足的人群的心理健康问题，并寻找治疗情绪和焦虑症的补充和替代方法。

他曾撰写或合作撰写了80篇原创文章，众多的书籍章节，和一本关于抑郁症的自我管理专著。

他的讲演题目：太极治疗自闭症的应用

Jian Kong, MD, MS, MPH, Associate professor of Harvard Medical School, Researcher scientist, Massachusetts General Hospital, his primary interest focuses on the brain mechanisms of pain and pain modulation. He is particularly interested in using combined brain imaging tools to investigate how noxious information is processed in the brain, how noxious information can be modulated by treatment (acupuncture) and the mind (placebo and nocebo), how the mind and acupuncture interact during this modulation process, and how acupuncture is different placebo. In addition, he is also interested in the brain network evoked by acupuncture stimulation and the reliability of the activation pattern in both healthy and patient’s population; and the brain modulation effect of meditation and Tai Chi practice. He has published more than 70 papers in above fields. Recently, he is also interested in the empathy & appraisal of pain, placebo analgesia in patients with Autism, as well as the treatment of autism using alternative medicine.

Title of speech: brain imaging studies related acupuncture, pain and autism

孔健, , 哈佛大学医学院副教授。主要研究领域包括应用不同的脑功能成像技术研究疼痛的感知，认知以及调节机制， 针灸和安慰剂镇痛作用的比较，人体预期对针灸治疗作用的影响，针灸刺激, 冥想，太极对大脑的调节作用。在相关领域发表论文70多篇。同时，他对自闭症病人的同情，评价以及安慰剂效应,以及使用传统医学治疗自闭症也非常感兴趣。

他的讲演题目是：针灸，疼痛及自闭症相关的大脑影像学研究

姚毓梅，美国认证行为分析师（BCBA），马萨诸塞州沃楚西学区（Wachusett Regional School District）的BCBA。她于1988年获得中国上海华东师范大学教育学学士，1996年在美国宾夕法尼亚州威得恩大学（Widener University）获得教育学硕士学位。威得恩大学毕业后，她从普通教育转向了特殊教育，并加入了马萨诸塞州新英格兰儿童中心（NECC）从事特殊教育（necc.org）。 NECC是美国全国研究特殊教育的中心z之一，是一个全国知名的私立非盈利性组织。在10年的工作中，她教过从4岁到22岁的自闭症和其他残疾的学生，获得了大量的临床工作/教育经验，同时她还参加了东北大学的高级培训计划，并完成了BCBA的考试课程的要求。她在2007年参加了严格的考试后获得BCBA。2008-2013她是马尔堡公立学校区（Marlborough Public School istrict）小学部的行为专家（Behavior Specialist）。在这段时间内，她有机会学习和了解到马萨诸塞州有关特殊教育和公共教育的法律法规。她还在美国国际学院完成了九门学校管理课程，现正在完成最后一门课以获取在学校管理的CAGS（高级研究生证书）。作为应用行为分析（ABA）专家在马尔堡学区工作的5年，她有很多机会运用自己在NECC积累的知识和经验。在公立和私立学校长期的工作使她有机会了解和总结私立学校与公办学校的区别，以及这些学校如何严格遵循马萨诸塞州联邦的法律法规（CMR），并用CMR来指导他们的教育和临床实践。目前，她在沃楚西特学区的13所学校（学前班到研究生高中）做BCBA顾问，给特殊教育教师、校长及其他相关人员提供ABA（应用行为分析）方面的指导。她还被ACCEPT聘为BCBA家庭服务的监督员，向周边16学区的学生家庭提供不同模式的行为教育服务。

Yumei Yao, Board Certified Behavior Analyst (BCBA) , Wachusett Regional School District in Massachusetts as a district BCBA. She received her bachelor's degree in school education at Eastern China Normal University in Shanghai, China in 1988, received Master's degree in education at Widener University in Pennsylvania, US in 1996. After graduated from Widener University, she shifted her career from regular education to special education and joined The New England Center for Children (NECC) in Massachusetts: necc.org. NECC is a nationally well-known private, non-profit organization that leads research and education in the field of special education in the U.S. During the 10 years working at NECC, she not only gained the clinical experience of working/educating students with autism and other disabilities from age 4 to 22, but also enrolled in an advanced training program at Northeastern University and completed the course requirements for sitting in the exam of BCBA. She received my BCBA in 2007. She then worked at Marlborough Public School District from 2008-2013. During that time period she had opportunities to learn the public education laws and regulations in Special Education in Massachusetts. She also completed nine courses in School Administration in a CAGS program (Certificate of Advanced Graduate Study) at American International College. Working as an ABA Program Specialist for 5 years in Marlborough school district, she has many opportunities to apply her knowledge and experiences gained at NECC. She also learned different philosophies between private schools and public schools and how strictly we should follow the Commonwealth Massachusetts Regulations and Laws (CMR) and to use CMR to guide our educational and clinical practices. Currently she is a BCBA Consultant providing ABA services (Applied Behavior Analysis) to 13 schools (pre-K to post graduate high school) in Wachusett School District to special education teachers, related service providers and building administrators. She also work as a home-based supervisor at ACCEPT Education Collaborative to provide various modules of home services to 16 school districts at home settings.

Title of speech: 1-2 of the following:

1. Overview of Autism and ABA

2. What is IEP and How to Develop an IEP

3. Functions of Behavior and How to Decrease Challenging Behavior

4. Discrete Trial Teaching and Task Analysis

5. Preference Assessment and Picture Activity Schedule

6. Communication Skills and AAC

7. How to Measure Behaviors

8. Reinforcement and Behavior Change

  Temple Grandin,PhD, Professor of animal science at Colorado State University, a best-selling author, an autistic activist, and a consultant to the livestock industry on animal behavior. She also invented the "hug box", a device to calm those on the autism spectrum. The subject of an award-winning, 2010 biographical film, Temple Grandin, she also was listed in the Time 100 list of the one hundred most influential people in the world in the "Heroes" category.

Grandin was born in Boston, Massachusetts, was diagnosed with autism as a child and went on to pursue work in psychology and animal science. She has become a leading advocate for autistic communities and has also written books and provided consultation on the humane treatment of animals. As a high-functioning autistic person, Grandin has been able to make sense of and articulate her unusual life experiences with rare depth.  In 2010, HBO released an Emmy Award winning film on Grandin’s life.  In 2009, she was named a fellow of the American Society of Agricultural and Biological Engineers. She is the recipient of several honorary degrees, and has been featured on a range of television and radio programs.

天宝·葛兰汀（Temple Grandin）生于波士顿，动物学家，动物保护主义者。时代周刊2010年100位“全球最具影响力人物”评选，英雄榜第5位。

天宝·葛兰汀是一个传奇。她出生不久，母亲发现她的行为跟别的小孩不一样。后来得知她患有自闭症。天宝称，自己是一个视觉思考者（visual thinker），她通过图像来思考。与此相比，她认为代数是很难的一个科目。十几岁的时候，她被带到了外婆家的农场，没想到她在那里找到了自己的乐园。

不妨看看她在TED演讲里是怎么描述这样的神奇际遇的： 她说演讲的一开头就说，在TED感觉就像在家一样，因为“这儿有很多同道中人”（是不是说很多TEDster都带有geek的基因？）。 作为她的兴趣之一，天宝很享受设计牲畜管理设备。有一次，一家养牛场的牛烦躁不安，不断冲撞牛栏，想要把它弄倒。天宝到那儿时看见旗杆上的美国国旗，就让他们摘了下来。“奶牛不喜欢飘扬的旗子”。激烈的抖动和强烈的颜色对比会激怒它们。她从奶牛的角度出发，像奶牛一样思考，寻找一切会激怒奶牛的事物。

“我以想象的方式看电影”。当你向“普通人”提起教堂尖顶的时候，他们想到的都是些泛泛的一般的典型的尖顶。而天宝看到的却是“谷歌图片”/一个图片库。她见过的所有教堂尖顶，像过电影似的浮现在脑海中。她可以在任一张图片上停下，并将它变为一段影像。“在设计牛畜管理设备时，这一切都变成了巨大的财富。我能在心里画草图”。

天宝超强的视觉能力是有证可循的。她展示了一张她的脑部扫描图，来和“普通人的大脑”（她的原话）进行对比。她大脑中掌管视觉的区域要明显大于常人！“我在图形处理方面的脑神经很发达”（作为交换，天宝说，我的社交神经发育迟缓）。天宝发达的视觉思维能力，使她能够洞察动物的心理。动物用图像，声音，气味思考，而非语言。“世界需要各种各样的头脑共同合作”。而她看到的却是，一个个不好交际的电脑小怪杰，没有人引领他们到科学的世界中。“我们要激励这帮怪怪的不受欢迎的孩子”。她在美国中部如是说，在硅谷外如是说，在其他电脑鬼才的圣地也如是说。老师们不知道该拿这帮孩子怎么办好。对于学校而言，取消车模课、美术课和制图课是天大的错误。

有三种自闭症患者，每一种在特定的领域都有优于常人的表现/不俗的表现：

视觉思考者（visual thinker）：艺术，设计，工业设计，摄影

模式思考者（pattern thinker）：数学家，程序员

语言思考者（verbal thinker）：新闻工作者，演员

天宝说，这个世界需要各种各样的思维模式/心智。也许，假如环境有利的话，自闭症患者往往可以成为社会的积极贡献者。而假如我们周遭的人对他们缺乏理解的话，即使是爱因斯坦（假如他生活在今天，肯定会被认为得了自闭症）也会被埋没。

天宝·葛兰汀虽然自幼患有自闭症，却拥有亚利桑那州立大学畜牧科学硕士，并于一九八八年获得伊利诺大学的畜牧科学博士学位。她是当今少数的牲畜处理设备设计、建造专家之一。她在此专业领域中，发表过上百篇学术论文，并经常性地巡回各地发表演说。本片即根据她的自传改编。

美国动物科学家、著名自闭症患者天宝·葛兰汀（Temple Grandin），最近接受了HBO电视频道的独家专访，讲述自己的故事。HBO频道首次推出自闭症题材的故事片，她便是女主角克莱尔·丹尼斯 (Claire Danes）的原型：事业辉煌的动物科学家，却举止笨拙，缺乏社交能力，或者正是这点也让她在两个领域里都取得了巨大成就：人道主义屠宰场设计师，直言不讳的自闭症作家。

Mike Zhaoxi Wang, MD, PhD, Research Scientist at public health and education, Harvard School of Public Health. He was trained in Beijing Medical University, Uniformed Services University of the Health Science (Bethesda, MD）and John Hopkins University. His researches involve gene mapping in complex human diseases, and other translational medicine projects funded by NIH.

王朝曦博士，哈佛大学公共卫生学院研究员，治愈自闭症研究所研究员。

Raymond K.Wang, Freshman of Department of Math, class 2015, University of Massachusetts Lowell，Autistic individual, co-founder and president of life long buddy project. 王睿萌，麻州州立大学数学系2015届新生，自闭症患者, 自闭症终身伴侣项目的共同创始人及主席。www.lifelongbuddy.com

Andrew Luo, 11^th grader of Boston Latin School, co-founder and president of AutiChange Iniative. 罗安竺，波士顿拉丁学校十一年级学生，自闭症交流项目共同创始人及主席。www.autiChange.us

Bryan K Wang, 10^th grader of Lexington High School, younger brother of an autistic individual, co-founder and president of AutiChange Iniative. 王博然，勒星顿高中十年级学生，自闭症患者的弟弟，自闭症交流项目共同创始人及主席。www.autiChange.us